ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-542X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer ; volume:14 ; number:2 ; day:14 ; month:3 ; year:2012 ; pages:1-12 ; date:4.2012
Breast cancer research ; 14, Heft 2 (14.3.2012), 1-12, 4.2012

Beteiligte Personen und Organisationen
Pinhel, Isabel
Hills, Margaret
Drury, Suzanne
Salter, Janine
Sumo, Georges
A'Hern, Roger
Bliss, Judith M.
Sestak, Ivana
Cuzick, Jack
Barrett-Lee, Peter
Harris, Adrian
Dowsett, Mitch
SpringerLink (Online service)

DOI
10.1186/bcr3145
URN
urn:nbn:de:1111-2016032414940
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:50 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Pinhel, Isabel
  • Hills, Margaret
  • Drury, Suzanne
  • Salter, Janine
  • Sumo, Georges
  • A'Hern, Roger
  • Bliss, Judith M.
  • Sestak, Ivana
  • Cuzick, Jack
  • Barrett-Lee, Peter
  • Harris, Adrian
  • Dowsett, Mitch
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells

Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells

Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy

Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy

Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells

Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases

Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines

Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines

Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells

Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells

Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells

Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue

Visualisation of HER2 homodimers in single cells from HER2 overexpressing primary formalin fixed paraffin embedded tumour tissue

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation

MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation

Verbundene Objekte